Available MTC data

The Mexican Teachers’ Cohort (MTC) is a prospective observational study.

Over 15 years, cohort participants have completed self-reported lifestyle questionnaires and attended health assessments as part of the clinical subcohort.

Baseline and follow-up evaluation

In 2006 the MTC began the baseline evaluation in two states: Jalisco and Veracruz. This “feasibility evaluation” phase ended in 2007.

Between 2008 and 2010 the baseline evaluation was expanded to 10 more states: Baja California, Chiapas, Mexico City, Durango, Guanajuato, Hidalgo, Nuevo León, Sonora, Yucatán, and expanded the sample of Jalisco and Veracruz.

In 2011, the first follow-up cycle began for the entire cohort, with a response rate of 83%. The second general evaluation cycle began in 2014 and ends in 2021 with a response of 62%.

In 2022 we have started the third follow-up cycle of the cohort.

Summary of available MTC data by follow-up cycle

The data on risk factors and health conditions have been collected through the baseline and follow-up questionnaires. Below is a summary of the main groups of variables available per evaluation cycle.
Please refer to the questionnaires for detailed information.

To correctly display all the data, use your fingers to scroll sideways

Summary of data on health on risk factors and health conditions by follow-up cycle

Year of evaluation
Number of participants (n)
2006
27,979
2008
106,456
2011
94,527
2014
69,970*
2022
In progress
Body weight
Physical activity
Smoking status
Diet (FFQ)
Diet in adolescence
Reproductive health
Air pollution
Migraine
Medicines
Depression (PHQ-9)
Adverse childhood experiences (ACE)
Sleep quality (PSQI)
Perceived Stress Scale (PSS-4)
Year of evaluation
Number of participants (n)
2006
27,979
2008
106,456
2011
94,527
2014
69,970*
2022
In progress
Body weight
Physical activity
Smoking status
Diet (FFQ)
Diet in adolescence
Reproductive health
Air pollution
Migraine
Medicines
Depression (PHQ-9)
Adverse childhood experiences (ACE)
Sleep quality (PSQI)
Perceived Stress Scale (PSS-4)

Summary of data on health outcomes by follow-up cycle

Year of evaluation
Number of participants (n)
2006
27,979
2008
106,456
2011
94,527
2014
69,970*
2022
In progress
Severe acne
Alzheimer's Disease
Rheumatoid arthritis
Asthma
Stroke
Cervical cancer
Breast cancer
Other cancer
Cataracts
Depression
Diabetes
Gestational diabetes/preeclampsia
Liver disease or cirrhosis
Kidney disease
Thyroid disease
COPD
Multiple sclerosis
Hip fracture
Hepatitis B o C
Hypercholesterolemia
Hypertension
Heart attack
Migraine
Polycystic ovary syndrome
Parkinson's disease
Gallstones
Year of evaluation
Number of participants (n)
2006
27,979
2008
106,456
2011
94,527
2014
69,970*
2022
In progress
Severe acne
Alzheimer's Disease
Rheumatoid arthritis
Asthma
Stroke
Cervical cancer
Breast cancer
Other cancer
Cataracts
Depression
Diabetes
Gestational diabetes/preeclampsia
Liver disease or cirrhosis
Kidney disease
Thyroid disease
COPD
Multiple sclerosis
Hip fracture
Hepatitis B o C
Hypercholesterolemia
Hypertension
Heart attack
Migraine
Polycystic ovary syndrome
Parkinson's disease
Gallstones
Mortality

En Mortality es Causes of death up to 2019 (n=2,140)

Clinical subcohort and biobank

Based on the the clinical evaluations, the MTC clinical subcohort was formed.

The main areas that were evaluated during the clinical sessions are shown below. For more details, consult the questionnaires.

To correctly display all the data, use your fingers to scroll sideways

Clinical subcohort

VeracruzJaliscoHidalgoCDMX-1ChiapasYucatánNuevo LeónCDMX-2
Year
Participants (n)
2007
1,034
2007
999
2010
1,07
2010
961
2012
909
2013
716
2016
765
2017
380
Anthropometry
Physical activity
Breast density
Blood pressure
VaSera
Intima Media Thickness (IMT)
Lipid profile
Blood count
Inflammation biomarkers
Fatty acids
Hair sample
VeracruzJaliscoHidalgoCDMX-1ChiapasYucatánNuevo LeónCDMX-2
Year
Participants (n)
2007
1,034
2007
999
2010
1,07
2010
961
2012
909
2013
716
2016
765
2017
380
Anthropometry
Physical activity
Breast density
Blood pressure
VaSera
Intima Media Thickness (IMT)
Lipid profile
Blood count
Inflammation biomarkers
Fatty acids
Hair sample

The bank of biological samples is protected in the National Institute of Public Health.